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Abstract
Background and Aim The extent of penumbra tissue and outcome in stroke patients depend on the collateral cranial vascula-
ture. To provide optimal individualized care for stroke patients in the emergency room setting we investigated the predictive 
capability of a stringent evaluation of the collateral vessels in ischemic stroke on clinical outcome and infarct size.
Methods We retrospectively studied uniform clinical and radiological data of 686 consecutive patients admitted to the emer-
gency department with suspected acute ischemic stroke. Cranial collateral vasculature status was graded using the initial 
CT-angiography. Outcome was measured by mRS, NIHSS and final infarct size at hospital discharge. All data were used to 
build a linear regression model to predict the patients´ outcome.
Results Univariate and multivariate analyses showed significant effects of the whole brain collateral vessel score on all out-
come variables. Atherosclerosis and piale collateral status were associated with the final infarct volume (FIV). Atherosclerosis 
and age were associated with the NIHSS at discharge. The presence of atherosclerosis, glucose level on admission and age 
were associated with the mRS at discharge. The multivariate models were able to predict 29% of the variance of the mRS at 
discharge, 24% of the variance in FIV and 17% of the variance of the NIHSS at discharge. The whole brain collateral status 
and the presence of atherosclerosis were the most relevant predictors for the clinical and radiological outcome.
Conclusion The whole brain collateral vasculature status is clearly associated with clinical and radiological outcome but 
in a multivariate model seems not sufficiently predictive for FIV, mRS and NIHSS outcome at discharge in non-preselected 
patients admitted to the emergency department with ischemic stroke.
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Introduction
In ischemic stroke artery occlusion leads to the hypoper-
fusion of the subsequent areas within the territory of the 
occluded vessel. If perfusion is less than 10 mL/100 g/min, 
nerve cells are irreversibly damaged within minutes [1]. If 
cerebral blood flow is partially reduced nerve cells cease to 
function but are still structurally intact and are considered 
potentially salvable tissue which makes them the target of 
thrombolytic therapy [2]. Various studies have shown that 
patients with good collateral status have larger ischemic 
penumbra, smaller infarct size and better outcome following 
thrombolysis and recanalization procedures [3, 4].
We aimed to predict clinical outcome on the grounds of 
the general collateral vessel status on the initial CT-angi-
ography to develop an overall score to identify patients 
with a low collateral status that might profit from a more 
aggressive interventional therapy thereby facilitating a more 
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personalized care of stroke patients in general. CT-angiogra-
phy was chosen because it is fast, easily applicable, widely 
available and does not require additional time-consuming 
image processing and reflects general medical practice.
Methods
Patients
We retrospectively studied the clinical and radiological data 
of 686 patients that were admitted to the tertiary referral 
center with an acute stroke and obtained a full radiological 
work-up [native CT, supra-aortal CT angiography (CTA) 
and a dedicated follow-up examination (cranial MRI or CT)] 
to quantify the final lesion size and location of the ischemic 
stroke (excluded: n = 156; data quality, n = 69; alternative 
diagnosis, n = 87, final analysis n = 530).
Predictor‑variables
The entire cranial collateral vasculature status of the patients 
was evaluated by applying an in-house scoring sheet to the 
initial CT-angiography. All vessels were graded by one expe-
rienced clinician who was blinded for the other data and 
diagnosis at the time of evaluation (Table 1).
For the comprehensive arterial vasculature status score of 
the brain the left and right sides were added together to obtain 
one value per vessel assuming that atherosclerotic changes 
are evenly distributed in both hemispheres. The scores of the 
anterior cerebral artery (ACA-), middle (MCA-), posterior 
(PCA-) segments were also summed up but an additional 
weighting factor was introduced as atherosclerosis located 
more proximal in the course of the vessel would produce 
a more devastating effect on clinical outcome. The ACA-
segments were calculated as ACA = 2 × A1 + A2 while the 
other two were calculated as MCA = 4 × M1 + 2 × M2 + M3 
and PCA = 4 × P1 + 2 × P2 + P3. The segments of the internal 
carotid artery were summarized in one ICA factor.
Relevant co-factors such as age, sex, atherosclerosis, 
infections, nicotine abuse and statin consumption, symptom 
onset, time to door and time to treatment were included. Ath-
erosclerosis was recorded if CT angiography showed intra-
vascular calcifications or hypodense plaques attached to the 
arterial wall. The applied intervention (none, iv thromboly-
sis, arterial thrombolysis or bridging lysis in combination 
with thrombectomy) and the infarct region were examined 
as well.
Outcome‑variables
Final infarct size, National Institutes of Health Stroke Scale 
Score (NIHSS), and modified Ranking Scale (mRS) at the 
time of discharge were used as dedicated outcome variables 
(median 8 days). The infarct size was manually measured 
based on the high resolution CT or diffusion-weighted MR 
images at least 48 h after symptom onset.
Modelling
The data analysis and statistical modeling were performed 
using SPSS (Version 23.0.0.0, Armonk, NY, IBM Corp.). 
To test the effect of risk factors, demographic variables, col-
lateral status and treatment on functional outcome univariate 
models were computed for each of the outcome variables 
(Cramers’ V, χ2 tests for metric variables, continuous vari-
ables were tested using Pearson’s r). To predict the outcome 
of the three variables linear regression models were applied. 
In a second analysis step, we used a MANOVA approach to 
account for possible interactions of the dependent variables. 
Initially, the entire dataset was analyzed using all available 
variables as predictors. In a second step, only MCA territory 
strokes and different stroke volumes were considered.
Standard protocol approvals and patient consents
The study was performed in accordance with the 1964 Dec-
laration of Helsinki and was approved by the local ethics 
Table 1  Grading score for the affected vascular territories
VA vertebral artery, BAS basilar artery, PCA posterior cerebral artery, 
Pcom posterior communicating artery, ICA internal carotid artery, 
ACA anterior cerebral artery, Acom anterior communicating artery, 
MCA middle cerebral artery, PICA posterior inferior cerebellar artery, 
AICA anterior inferior cerebellar artery, SCA superior cerebellar 
artery











 0: 0–8 pial arteries visible
 1: 9–11 pial arteries visible
 2: > 11 piale arteries visible
Piale cerebellar arteries:
 0: not visible / not assessable
 1: < 3 piale arteries visible
 2: > 2 piale arteries visible
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committee. Written consent for data usage was obtained 
from all patients.
Data availability
The dataset is not publicly available but can be obtained 
from the corresponding authors on reasonable request.
Results
Predictor‑variables
Demographic data are shown in Table 2, the distribution 
of vascular territories among the 530 patients is shown in 
Fig. 1d. In 91 patients the diagnosis was later changed clini-
cally to transient ischemic attack (TIA). 
Outcome‑variables
The median infarct volume (FIV) was 2.76 ml (median 
1.94 ml), for the distribution of FIV across the patient 
population see Table 2. Of all patients, 3.2% were evalu-
ated within the first hour of symptom onset. In 16.4% (87) 
of the patients the exact time of symptom onset could not 
be determined (Fig. 1a, b). A third of the patients (32.2%, 
n = 171) received iv thrombolysis with rt-PA, another 32% 
of the investigated cohort was treated with either intraarterial 
thrombolysis or in combination with thrombectomy (n = 3) 
or applying a bridging lysis regimen and thrombectomy 
(n = 9). More than half of the patients (55.1%, n = 292) did 
not receive any acute intervention.
The median NIHSS at onset was 6.0 and 1 at the time of 
discharge from the hospital. The initial mRS was 3.0 and 2.0 
for the follow-up measurement at discharge.
The correlation between the mRS and the NIHSS was 
0.634 (p < 0.001) and the correlation between mRS and 
infarct size was 0.622 (p < 0.001). The correlation coefficient 
of the NIHSS with infarct volume was 0.541 (p < 0.001).
Univariate analysis
Univariate analysis showed an effect for the presence of ath-
erosclerosis in the CTA on admission, elevated blood glucose 
level on admission, piale collateral status, baseline NIHSS and 
therapy on the FIV. Atherosclerosis, age, treatment, age and 
stroke severity were significantly related to NIHSS score at 
discharge. Finally, atherosclerosis, glucose level on admission, 
age and stroke severity were significantly associated with the 
mRS. The whole brain vessel score was correlated with all 
three outcome variables in univariate analysis when consid-
ering all patients as well as the subgroup of MCA territory 
strokes only. (Table 3). No significant effect on the three out-
come variables was found for collateral status in severe stroke 
(i.e., NIHSS > 17, n = 36).
Regression models
We first estimated a linear regression model using whole brain 
collateral status score, piale collateral score, atherosclerosis, 
elevated blood glucose level on admission, statine medication, 
infectious constellation (clinical or laboratory tests), history of 
smoking, age, sex and the type of applied treatment as pre-
dictor variables. This first model including the whole dataset 
explained 29.0% of the variance when predicting the mRS, 
24% when predicting the FIV and 17% when predicting the 
NIHSS. The predictive capacity changed only moderately when 
including only strokes in the MCA territory or medium volume 
strokes (15–100 ml). The whole brain collateral status was the 
strongest predictor for all outcome measures. Apart from the 
collateral status, the presence of atherosclerosis was predictive 
of the NIHSS at discharge in all models, while an elevated 
glucose level on admission and age were predictive of the mRS 
at discharge when considering the whole data set and medium 
to large (non-malignant) volume strokes (FIV 15–100 ml). We 
attempted to analyze the subgroup of malignant profile / severe 
strokes (i.e., infarct volume > 100 ml, NIHSS > 17), however, 
this analysis did not yield reliable enough results due to the 
small number of cases in the sub-analysis (see Table 4) [5].
In addition, we reanalyzed the data using a MANOVA 
approach using the same variables as predictors of functional 
and radiological outcome (see Fig. 2). Using this complemen-
tary multivariate analysis approach we could confirm our find-
ings from the original linear regression models. An analysis of 
medium size and malignant profile strokes was not methodo-
logically possible with this approach. The model was perform-
ing best when using mRs at discharge as dedicated outcome 
variable while it was least predictive of the FIV when consid-
ering the whole data set as well as MCA territory strokes only.
Discussion
We aimed to introduce a simple grading algorithm for col-
lateral vessels in the emergency room setting using the con-
ventional diagnostic measures that are widely available for 
everyday clinical practice.
On a univariate level we could replicate findings that 
whole brain collateral vessel status as well as risk factors 
such as atherosclerosis, elevated glucose levels on admission 
as well as interventional treatment are related to the func-
tional and radiological outcome of the patients [6–10]. This 
is of particular interest since we used a novel scoring method 
to evaluate the collateral vessel status of the whole brain.
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However, using a regression model our data show in a 
large sample of acute stroke patients that the status of the 
collateral vessels on a whole brain level using CTA is not 
reliably predictive of the final infarct size, mRs and NIHSS 
on a multivariate level. This was true for both multivariate 
analysis approaches used in our study. The predictive capac-
ity of the model was moderately increased when including 
only strokes in the territory of the MCA. However, with the 
described model we were able to account for 29% of the 
variance at most.
Our data shed a new light on several clinical trials that 
demonstrated the importance of collateral status on clini-
cal outcome using different grading techniques to evaluate 
patients’ collateral status [11–15]. Most of these studies 
only included patients with large artery occlusion that were 
potentially eligible for thrombectomy whereas in our study, 
median infarct volume and the rate of clinically severe stroke 
(i.e., NIHSS > 17) was rather small representing an actual 
natural cohort. There is also great variability in the methods 
and grading systems used to quantify collateral perfusion 
Table 2  Demographics, 
cofactors and treatment 
outcomes




NIHSS admission (median, IQR) 6.0 (8.0)
NIHSS discharge (median, IQR) 1 (4.0)
mRS admission (median, IQR) 3.0 (2.0)
mRS discharge (median, IQR) 2.0 (2.0)
Infarct volume (median, IQR) 1.94 ml (27.8)
Atherosclerosis (n/%) 175 (33%)
Smoking (n/%) 207 (39.1%)
Elevated glucose level on admission (n/%) 28 (5.3%)
Infection (n/%) 13 (2.5%)
Intervention (n/%)
 IV thrombolysis 171 (32.2%)
 IA thrombolysis (± bridging) 32 (6%)
 Mechanical thrombectomy 11 (2%)
 No intervention 292 (55.1%)





Treatment outcomes (median, IQR) FIV (ml) NIHSS mRS
 IV thrombolysis 5.4 (56.68) 2.0 (6.0) 2.0 (3.0)
 IA thrombolysis (± bridging) 77.1 (223.4) 3.0 (12.0) 4.5 (2.5)
 Mechanical thrombectomy 36.6 (55.35) 5 (.5) 2.0 (4.0)
 No intervention 0.56 (8.04) 1 (4.0) 1.0 (3.0)
MCA territory only
LVOS 105 (31.0%, 90 M1 segment, 15 ICA)





Treatment outcomes (median, IQR) FIV (ml) NIHSS mRS
 IV thrombolysis 4.86 (59.3) 2 (6.0) 2 (2.3)
 IA thrombolysis (± bridging) 113.81 (222.4) 5.5 (13.3) 4.0 (3.0)
 Mechanical thrombectomy 35.4 (44.5) 5 (6.0) 2 (3.3)
 No intervention 1.2 (22.8) 1.5 (5.0) 2.0 (3.0)
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that has to be accounted for [4, 16]. In summary, our cohort 
is far more heterogenous and closer to a real-life scenario 
because we included all patients admitted with the suspicion 
of an ischemic stroke/TIA [4, 16–18].
We conclude that a whole-brain vessel score for all 
patients regardless of the vascular territory involved or 
the location of the occluded vessel does not appear to help 
to prospectively identify patients for a more aggressive 
therapeutic approach. It seems that only the dedicated 
territorial evaluation concerning the exact location of the 
ischemic lesion and its surrounding vessels during actual 
interventional angiography or a combination with perfu-
sion measures would be suitable to better predict the clini-
cal outcome on a multivariate level. It might be possible 
that grading of the vascular collateral status is more help-
ful in selected patients with large artery occlusion and/
or severe strokes. This question should be addressed in 
future studies.
It is noteworthy that in our dataset sometimes over 50% of 
the variance for the respective model could not be explained 
by any of our variables. This indicates that lot more than the 
obvious patient inherent factors, such as age and gender or 
comorbidity, as documented by statin consumption, smok-
ing or infectious complications during the hospital stay and 
the status of the collateral vasculature seem to contribute to 
the final infarct size and persisting clinical deficit. Factors 
that might change the magnitude of cerebral collateral blood 
flow (genetic or preexisting conditions, actual hemodynamic 
situation during the CT-angiography) that are not evident at 
the time of arrival in the emergency department might also 
play into the relatively low amount of variance explained by 
our model in general [1, 19].
However, even in the pooled analysis of multiple large 
multicenter trials of therapeutic interventions on stroke 
outcome which demonstrated the effect of mechanical 
thrombectomy on clinical outcome, only 12% of the clini-
cal effect was explained by final infarct volume. Therefore, 
apart from the unknowns described above this seems to be 
an inherent limitation of the statistical methods used in our 
and the aforementioned study to predict outcome based on 
values of estimation of FIV [20].
Future studies in larger populations should emphasize 
the role of vascular territory involved and classify the 
pathophysiological mechanism (large artery occlusion 
vs. lacunar) in more detail. This has been shown to be 
effective for large artery atherosclerosis vs. cardioembolic 
strokes and the effect of adjacent collateral vessels com-
pared with the contralateral non-affected hemisphere. A 
prediction approach using regional weights should then 
allow for more precise prediction models than a whole 
brain analysis since the presence of collateral vasculature 
is known to differ between spatially distinct regions of the 
brain [15, 21]. This could help us reach a personalized 
medicine model in stroke when predicting final infarct size 
Fig. 1  a–c show the effect of symptom duration before getting to the emergency department on FIV; NIHSS and mRS. d Relative distribution of 
the affected vascular territories
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Table 3  Univariate analysis of co factors and collateral status on FIV, NIHSS and mRS at discharge (Cramers’ V, Pearson’s r, p < 0.05)
FIV All patients MCA territory only
Effect size Sig Effect size Sig
Cramers V p Cramers V p
Atherosclerosis 0.122 0.0094 0.12 0.3
Infection 0.1 0.232 0.088 0.618
Glucose 0.18 0.003 0.177 0.03
Statine 0.066 0.638 0.107 0.471
Male sex 0.053 0.751 0.186 0.019
Smoking 0.032 0.937 0.157 0.096
Pearson’s r p Pearson’s r p
Age 0.39 0.39 0.011 0.853
Whole brain collateral vessel score − 0.459 < 0.0001 − 0.38 < 0.0001
Piale collaterals only − 0.209 < 0.0001 − 0.251 < 0.0001
Baseline NIHSS 0.59 < 0.0001 0.615 < 0.0001
NIHSS discharge 0.541 < 0.0001 0.423 < 0.0001
mRS discharge 0.622 < 0.0001 0.556 < 0.0001
Cramers V p Cramers V p
Therapy 0.414 < 0.0001 0.436 < 0.0001
NIHSS discharge Cramers V p Cramers V p
Atherosclerosis 0.151 0.008 0.156 0.034
Infection 0.059 0.474 0.093 0.298
Glucose 0.25  < 0.0001 0.221 0.001
Statine 0.04 0.722 0.076 0.449
Male sex 0.02 0.914 0.016 0.963
Smoking 0.039 0.957 0.054 0.672
Pearson’s r p Pearson’s r p
Age 0.125 0.01 0.108 0.074
Whole brain collateral vessel score − 0.305 < 0.0001 − 0.33 < 0.0001
Piale collaterals only 0.037 0.46 − 0.1 0.109
Baseline NIHSS 0.677 < 0.0001 0.638 < 0.0001
mRS discharge 0.559 < 0.0001 0.539 < 0.0001
Cramers V p Cramers V p
Therapy 0.2 0.029 0.23 0.063
mRS discharge Cramers V p Cramers V p
Atherosclerosis 0.217 < 0.0001 0.25 < 0.0001
Infection 0.05 0.319 − 0.27 0.665
Glucose 0.122 0.014 0.122 0.052
Statine 0.054 0.284 − 0.059 0.349
Male sex 0.01 0.839 0.033 0.596
Smoking 0.099 0.139 0.005 0.924
Pearson’s r p Pearson’s r p
Age 0.208 < 0.0001 0.235 < 0.0001
Whole brain collateral vessel score − 0.446 < 0.0001 -0.436 < 0.0001
Piale collaterals only − 0.035 0.5 -0.133 0.04
Baseline NIHSS 0.636 < 0.0001 0.56 < 0.0001
NIHSS discharge 0.586 < 0.0001 0.539 < 0.0001
FIV 0.264 < 0.0001 0.387 < 0.0001
Cramers V p
Therapy 0.225 < 0.0001 0.177 0.09
2019Journal of Neurology (2020) 267:2013–2021 
1 3
Table 4  Multivariate linear regression models predicting the variance of FIV, NIHSS and mRS at discharge (p < 0.05)
All territories Final infarct volume (FIV) NIHSS discharge mRS discharge
t p ß t ß t p ß
Whole brain vessel score − 6.91 < 0.001 − 6.91 -5.62 − 0.30 − 7.19 < 0.001 − 0.37
Piale collaterals only − 1.94 0.053 − 1.94 -0.39 − 0.02 0.10 0.923 0.01
Atherosclerosis − 0.55 0.58 − 0.55 2.04 0.11 − 0.09 0.926 − 0.01
Glucose level 0.34 0.738 0.34 2.47 0.12 2.13 0.034 0.10
Statine − 0.01 0.996 − 0.01 -0.65 − 0.03 − 1.36 0.174 − 0.06
Smoking 1.76 0.079 1.76 0.51 0.02 1.37 0.173 0.07
Infection − 0.61 0.543 − 0.61 1.07 0.05 1.76 0.08 0.08
Age 0.33 0.742 0.33 1.22 0.06 4.71 < 0.001 0.24
Male sex 1.83 0.067 1.83 0.20 0.01 0.36 0.72 0.02
IV thrombolysis 2.62 0.009 2.62 0.65 0.03 2.43 0.016 0.12
IA thrombolysis (bridging) 4.77 < 0.001 4.77 0.90 0.05 1.96 0.051 0.10
Thrombectomy − 0.37 0.711 − 0.37 2.72 0.131 1.115 0.266 0.052
Overall model F df p adj R2 F df p adj R2 F df p adj R2
11.04 12,355 < 0.0001 0.24 7.224 12,361 < 0.0001 0.17 12.519 12,333 < 0.0001 0.29
MCA only Final infarct volume (FIV) NIHSS discharge mRS discharge
t p ß t ß t p ß
WholeBrain vessel score − 4.49 < 0.001 − 0.29 − 5.62 − 0.30 − 6 < 0.001 − 0.38
Piale collaterals only − 2.13 0.03 − 0.13 − 0.39 − 0.02 − 0.68 0.497 − 0.04
Atherosclerosis − 0.22 0.83 − 0.01 2.04 0.11 0.07 0.942 0.00
Glucose level 1.15 0.25 0.07 2.47 0.12 2.11 0.036 0.12
Statine 0.57 0.57 0.03 − 0.65 − 0.03 − 1.07 0.287 − 0.06
Smoking 1.91 0.06 0.11 0.51 0.02 0.36 0.716 0.02
Infection − 1.11 0.27 − 0.07 1.07 0.05 0.85 0.396 0.05
Age 0.21 0.83 0.01 1.22 0.06 4.72 < 0.001 0.31
Male sex 2.98 < 0.001 0.18 0.20 0.01 0.78 0.437 0.05
IV thrombolysis 1.14 0.26 0.07 0.65 0.03 − 0.38 0.705 − 0.02
IA thrombolysis (bridging) 3.68 < 0.001 0.23 0.90 0.05 0.78 0.437 0.05
Thrombectomy − 0.61 0.541 − 0.04 2.715 0.131 − 0.04 0.968 − 0.002
Overall model F df p adj R2 F df p adj R2 F df p adj R2
6.25 12,228 < 0.001 0.21 7.224 12,361 < 0.001 0.17 8.571 12,215 < 0.001 0.29
Malignant (FIV > 100 ml) NIHSS discharge mRS discharge
F df p adj R2 F df p adj R2
Overall model 0.593 10,26 0.805 na 0.813 10,23 0.619 na
Medium FIV (15–100 ml) NIHSS discharge mRS discharge
t p ß t p ß
WholeBrain vessel score − 5.62 < 0.001 − 0.30 − 7.19 < 0.001 − 0.37
Piale collaterals only − 0.39 0.70 − 0.02 0.1 0.923 0.01
Atherosclerosis 2.04 0.04 0.11 − 0.09 0.926 − 0.01
Glucose level 2.47 0.01 0.12 2.13 0.034 0.10
Statine − 0.65 0.52 − 0.03 − 1.36 0.174 − 0.06
Smoking 0.51 0.61 0.02 1.37 0.173 0.07
Infection 1.07 0.29 0.05 1.76 0.08 0.08
Age 1.22 0.22 0.06 4.71 < 0.001 0.24
Male sex 0.20 0.84 0.01 0.36 0.72 0.02
IV thrombolysis 0.65 0.52 0.03 2.43 0.016 0.12
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and more importantly clinical outcome by evaluating the 
status of the collateral vasculature of the brain at event 
onset.
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